Sunday, January 22, 2017 - 7:17pm
Public Domain
News, Asset Sales, Tech, Media
Friday, January 20, 2017 - 2:46pm
Public Domain

Northcoast Research said Signet Jewelers Ltd. (NYSE: SIG) is leaning to a sale of its credit business, a move that could potentially lift its valuation multiples and result in increased returns for shareholders.

Read more
Friday, January 20, 2017 - 8:43am

The massive post-election rally experienced by the big banks last year, as well as the continued suggestion of impending banking reforms under the Trump administration and republican-dominated congress, has many people curious to see what role smaller banks will play in the coming years.

Read more
Thursday, January 12, 2017 - 3:04pm
Public Domain

Wells Fargo has upgraded Brookdale Senior Living, Inc. (NYSE: BKD) to Outperform from Market Perform on higher probability of a Read more

Wednesday, January 11, 2017 - 10:59am
Public Domain

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has taken its first significant steps toward de-levering its balance sheet, announcing the divestiture of Dendreon and several dermatology brands for combined cash consideration of ~2.1 billion,” Canaccord Genuity’s Neil Marouka said in a note.

Read more
Tuesday, January 10, 2017 - 11:59am
Public Domain

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were seen soaring 9.3 percent on Tuesday after the company announced the sale of $2.1 billion in assets to raise money to pay down the company’s

Read more
Tuesday, January 10, 2017 - 11:12am
https://commons.wikimedia.org/w/index.php?curid=39819164

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced an agreement to sell its CeraVe, AcneFree and AMBI Skincare brands to L'Oreal SA (ADR) (OTC: LRLCY) for

Read more
Tuesday, January 10, 2017 - 11:03am
https://commons.wikimedia.org/wiki/File:McDonalds_in_Sanya,_China.JPG

Baird says McDonald's Corporation (NYSE: MCD) is transitioning to a higher ROIC business model, and its move to sell the majority of its China business could lead to an attractive

Read more
Tuesday, January 10, 2017 - 10:36am
Public Domain

Baird believes Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is taking steps in the right direction by announcing the sale of its metastatic pancreatic cancer drug Onivyde to French drug maker Ipsen

Read more